Skip to main content
. 2018 Apr 3;3(3):218–224. doi: 10.1016/j.bioactmat.2018.03.003

Table 2.

Percentage inhibition of the clinical pathogens by FG and FU.

Pathogens Percentage of Inhibition by FG
Percentage of Inhibition by FU
Concentrations (mg/mL)
Concentrations (mg/mL)
0.5 1 2 0.5 1 2
GRAM NEGATIVE STRAINS Escherichia coli 48.4 ± 0.1 65.9 ± 0.1 74.2 ± 0.1 31.3 ± 0.4 56.1 ± 0.2 64.3 ± 0.1
Pseudomonas aeruginosa 36.2 ± 0.04 60.4 70.1 ± 0.2 21.6 ± 0.4 54.6 ± 0.3 61.3 ± 0.1
Serratia marcecens 38.3 ± 0.3 63.3 71.7 ± 0.2 19.5 ± 0.4 49.8 ± 0.1 59.2 ± 0.1
Shigella sp. 38.1 ± 0.1 54.4 ± 0.1 66.6 ± 0.1 19.3 ± 0.1 51.9 ± 0.1 62.6 ± 0.1
Proteus mirabilis 37 ± 0.1 50.3 ± 0.1 65.7 ± 0.1 15.1 ± 0.2 50.3 ± 0.1 64.6 ± 0.2
Salmonella sp. 26.4 ± 0.1 59.1 ± 0.2 70.7 ± 0.2 18.5 ± 0.1 47.8 ± 0.1 64.4 ± 0.1
Klebsiella pneumoniae 29 ± 0.2 61.3 ± 0.1 72.0 ± 0.1 23.1 ± 0.1 42.1 ± 0.2 57.5 ± 0.1
GRAM POSITIVE STRAINS Enterococcus sp. 51.6 ± 0.4 73.7 ± 0.2 75.1 ± 0.1 57.1 ± 0.04 71.4 ± 0.04 80.2 ± 0.04
Staphylococcus aureus 52.8 ± 0.2 73.9 ± 0.1 75.6 ± 0.1 58.3 ± 0.1 73.1 ± 0.04 81 ± 0.04